Human bites are high-risk wounds with an estimated 10% infection rate overall, but significantly higher rates in hand injuries and clenched-fist injuries (fight bites). [1] They carry complex polymicrobial bacteriology and potential for bloodborne pathogen transmission, requiring systematic evaluation and aggressive wound management. [2-3]
1. History
- Mechanism: Occlusal bite (direct biting) vs. clenched-fist injury (CFI/"fight bite" — punching someone in the mouth). Patients with CFI may be reluctant to disclose the true mechanism. [4]
- Timing: Time from injury to presentation — delays >12 hours significantly increase infection risk. [5]
- Location: Hand, face, ear/nose cartilage, extremity, trunk.
- Depth: Superficial abrasion vs. deep puncture vs. laceration with tissue loss.
- Circumstances: Assault, accidental (children at play), self-inflicted, abuse context (especially pediatric). [2]
- Tetanus immunization history: Number of doses, time since last booster. [6]
- Source person: Known vs. unknown; any known bloodborne pathogen risk (HIV, HBV, HCV status). [7-8]
- Symptoms since injury: Pain, swelling, erythema, drainage, fever, decreased ROM (especially hand).
2. Alarm Features
- Clenched-fist injury over MCP joints — high risk for septic arthritis, tenosynovitis, osteomyelitis [3-4]
- Signs of established infection: Purulent drainage, lymphangitis, rapidly spreading erythema, crepitus
- Systemic toxicity: Fever, tachycardia, rigors → concern for sepsis/DIC [2]
- Joint or tendon involvement: Decreased ROM, pain with passive extension, visible tendon/capsule violation
- Deep space hand infections: Thenar/hypothenar/midpalmar space swelling
- Tissue avulsion or devitalization
- Immunocompromised patient (diabetes, HIV, asplenia, chronic steroids) — higher risk of severe/invasive infection [9]
3. Medications
Prophylactic antibiotics — strongly recommended for all human bites (OR for infection reduction 0.02; 95% CI 0–0.33): [4][10]
- First-line: Amoxicillin-clavulanate 875/125 mg PO BID × 3–5 days [6][9]
- Penicillin allergy: Clindamycin + TMP-SMX, or moxifloxacin monotherapy, or ciprofloxacin/levofloxacin + metronidazole [6]
- IV options (for established infection): Ampicillin-sulbactam, ertapenem, or piperacillin-tazobactam [6][11]
Medications to avoid
- First-generation cephalosporins (no Eikenella corrodens coverage) [6]
- Macrolides (variable activity, poor anaerobic coverage) [6]
- Clindamycin alone (does not cover Eikenella) [6]
Key pearl: Eikenella corrodens is the hallmark pathogen of human bites and is resistant to first-generation cephalosporins, macrolides, clindamycin, and aminoglycosides. [3][6]
4. Diet
- No specific dietary triggers or restrictions.
- Ensure adequate hydration and nutrition to support wound healing.
- Diabetic patients should optimize glycemic control to reduce infection risk.
5. Review of Systems
- Constitutional: Fever, chills, malaise (systemic infection)
- MSK: Joint pain/swelling, decreased ROM (especially hand — septic arthritis, tenosynovitis)
- Skin: Spreading erythema, warmth, drainage, lymphangitis
- Neurologic: Numbness/tingling distal to wound (nerve injury)
- Vascular: Distal perfusion, capillary refill (vascular injury)
6. Collateral History and Family History
- Source person information: HIV, HBV, HCV status; IV drug use; visible oral bleeding or lesions at time of bite [7-8]
- Pediatric context: Consider non-accidental trauma/child abuse — human bites in children are commonly inflicted during play but may indicate abuse [2]
- Institutional setting: Developmental centers, psychiatric facilities — higher bite frequency [8]
- Family history is generally not relevant unless assessing immunocompromised states.
7. Risk Factors
High-risk wound features
- Hand location (especially over MCP joints) [3-4]
- Clenched-fist mechanism [4]
- Deep puncture wounds [4]
- Wounds over cartilage (ear, nose) [9]
- Delayed presentation (>12 hours) [5]
- Primary closure without observation period [5]
High-risk patient features
- Diabetes mellitus, immunosuppression, asplenia [9]
- Chronic steroid use
- Extremes of age
- Peripheral vascular disease
8. Differential Diagnosis
- Animal bite (dog, cat) — different microbiology (Pasteurella predominant); distinguish by history
- Puncture wound from other mechanism (nail, glass)
- Self-inflicted wound — consider psychiatric comorbidity
- Non-accidental trauma (pediatric) — bite mark pattern analysis may be needed
- Cellulitis/abscess from other etiology if presenting late with infection
- Necrotizing fasciitis — rapidly progressive, crepitus, systemic toxicity (cannot-miss diagnosis)
- Septic arthritis/osteomyelitis — especially with CFI over MCP joint
9. Past Medical History
- Immunization status: Tetanus series completion, last booster date [6]
- HBV vaccination status: Documented response to vaccine [8]
- Immunocompromising conditions: Diabetes, HIV, organ transplant, chemotherapy, chronic steroids
- Prior bite injuries or wound infections
- Bleeding disorders or anticoagulant use (affects wound management)
- Prosthetic joints or hardware (risk of hematogenous seeding)
10. Physical Exam
- Wound assessment: Size, depth, tissue viability, foreign body (tooth fragment), tendon/joint capsule visibility
- Neurovascular exam distal to wound: Sensation (two-point discrimination for hand), capillary refill, pulses
- Tendon function: Test each tendon individually; for CFI, examine hand in both fist and open positions — tendon laceration may only be visible with the fist clenched [3-4]
- Range of motion: Active and passive; pain with passive motion suggests deep space infection or joint involvement
- Lymph node exam: Regional lymphadenopathy
- Signs of infection: Erythema, warmth, induration, fluctuance, purulent drainage, lymphangitis, crepitus
- Vital signs: Fever, tachycardia (systemic infection)
Pearl: For MCP lacerations, always examine with the fist clenched to replicate the position of injury — the extensor tendon laceration may retract proximally when the hand is opened. [4]
11. Lab Studies
- Uninfected wounds: Cultures are NOT indicated (poor correlation with subsequent infection) [2]
- Clinically infected wounds:
- Aerobic and anaerobic wound cultures (aspirate or tissue preferred over swabs) [2]
- Gram stain [2]
- CBC with differential
- CRP/ESR (baseline inflammatory markers)
- Blood cultures if systemic signs of infection
- Bloodborne pathogen assessment:
- Source person: HBV (HBsAg), HCV antibody, HIV testing [7-8]
- Victim: Baseline HBV (HBsAg, anti-HBs), HCV antibody, HIV [7-8]
- BMP if considering IV antibiotics or in patients with renal disease
12. Imaging
- X-ray of affected area: First-line for all hand bites and deep wounds
- CT or MRI: Consider if concern for deep space infection, abscess, osteomyelitis, or septic arthritis not clarified by plain films
- Imaging is unnecessary for superficial abrasions without signs of deep structure involvement
13. Special Tests
- Bite mark analysis: May be relevant in forensic/abuse cases
- Wound exploration: Essential for CFI — evaluate extensor tendon integrity and MCP joint capsule under direct visualization; often requires hand surgery consultation [3-4]
- Joint aspiration: If concern for septic arthritis (send for cell count, Gram stain, culture)
- Point-of-care ultrasound: Can identify abscess, foreign body, fluid collection
14. ECG
- Not routinely indicated.
- Consider if patient is septic or if planning procedural sedation for wound exploration/debridement.
15. Assessment
Human bites produce polymicrobial infections with a mix of aerobes (Streptococcus, S. aureus, Eikenella corrodens) and anaerobes (Fusobacterium, Peptostreptococcus, Prevotella, Porphyromonas). [2][6] Severity ranges from superficial abrasions to life-threatening deep space infections.
Severity stratification
- Low risk: Superficial abrasion/scratch, non-hand location, early presentation, immunocompetent
- Moderate risk: Laceration requiring closure, hand/cartilage location, delayed presentation
- High risk: CFI with joint/tendon involvement, established infection, immunocompromised host, systemic signs
Complications include cellulitis, abscess, lymphangitis, septic arthritis, tenosynovitis, osteomyelitis, and rarely endocarditis, meningitis, brain abscess, and DIC. [2]
16. Treatment Plan
Initial stabilization and wound care
- High-pressure irrigation with normal saline (minimum 150–250 mL via syringe with splash guard) [4][10]
- Debridement of devitalized tissue
- Wound exploration to assess depth and structural involvement
Wound closure: [4-5][12]
- Do NOT close: CFI/fight bites, puncture wounds, clinically infected wounds, wounds >12–24 hours old
- Delayed primary closure (3–5 days) is preferred for most human bite lacerations — lower infection rate than primary closure (12.6% vs 29.0%) with comparable cosmesis [5]
- May consider primary closure: Clean facial wounds <12 hours old (excellent blood supply) after thorough irrigation, with close follow-up [12]
Antibiotic prophylaxis — recommended for all human bites: [4][10]
- Amoxicillin-clavulanate 875/125 mg PO BID × 3–5 days [9]
- Alternatives per allergy as above
Established infection
- IV ampicillin-sulbactam 3 g q6h, or ertapenem 1 g IV daily, or piperacillin-tazobactam [6][11]
- Surgical debridement and drainage as indicated [11]
Tetanus prophylaxis: [6][13]
- Bite wounds are classified as "dirty wounds"
- Tdap/Td booster if ≥5 years since last dose
- TIG (tetanus immune globulin) if <3 doses or unknown vaccination history
Bloodborne pathogen prophylaxis: [7-8]
- HBV: If victim is unvaccinated or non-responder → HBIG + initiate HBV vaccine series
- HIV: nPEP is not routinely recommended for human bites; consider if visibly bloody saliva and source is known/suspected HIV-positive with detectable viremia [7]
- HCV: No prophylaxis available; baseline and follow-up testing
17. Disposition
Admit for
- CFI with joint/tendon involvement requiring operative exploration [3-4]
- Established deep space infection, septic arthritis, tenosynovitis, osteomyelitis
- Systemic signs of infection (sepsis)
- Failed outpatient therapy
- Need for IV antibiotics
- Immunocompromised patients with significant wounds
Discharge with
- Superficial wounds after irrigation and debridement
- Oral antibiotic prophylaxis prescribed
- Tetanus prophylaxis administered
- Reliable follow-up arranged within 24–48 hours
Consult triggers
- Hand surgery: All CFI over MCP joints, tendon/joint involvement, deep hand wounds [3-4]
- Plastic surgery: Complex facial wounds, tissue loss
- Infectious disease: Refractory infections, immunocompromised hosts, bloodborne pathogen exposure management
18. Follow Up / Return Precautions
- Wound check at 24–48 hours — essential for all human bites, especially if wound was left open for delayed closure [4]
- Daily dressing changes with topical antimicrobial and absorbent dressing [4]
Return immediately for
- Increasing redness, swelling, warmth, or pain
- Purulent drainage
- Red streaking (lymphangitis)
- Fever or chills
- Decreased range of motion (especially hand)
- Numbness or weakness distal to wound
Expected course: With appropriate irrigation, prophylactic antibiotics, and wound care, most uncomplicated human bites heal within 1–2 weeks. CFI and deep wounds may require prolonged antibiotic courses (7–14 days) and staged surgical management. [1][3]
Bloodborne pathogen follow-up: Repeat HCV and HIV testing at 6 weeks, 3 months, and 6 months post-exposure if source status is unknown or positive. [7-8]
References
1. Current Management of Human Bites. — Bunzli WF, Wright DH, Hoang AT, et al. Pharmacotherapy. 1998.
2. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
3. Human and Other Mammalian Bite Injuries of the Hand: Evaluation and Management. — Kennedy SA, Stoll LE, Lauder AS. The Journal of the American Academy of Orthopaedic Surgeons. 2015.
4. Current Management of Acute Cutaneous Wounds. — Singer AJ, Dagum AB. The New England Journal of Medicine. 2008.
5. Management of Human Bite Wounds in Children: A 9-Year Retrospective Study. — Ao W, Ma W, Zhang R, et al. The Journal of Surgical Research. 2025.
6. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
7. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025. — Tanner MR, O'Shea JG, Byrd KM, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2025.
8. Human Bites: Bloodborne Pathogen Risk and Postexposure Follow-Up Algorithm. — Lohiya GS, Tan-Figueroa L, Lohiya S, Lohiya S. Journal of the National Medical Association. 2013.
9. Antibiotic Prophylaxis in Injury: An American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. — Appelbaum RD, Farrell MS, Gelbard RB, et al. Trauma Surgery & Acute Care Open. 2023.
10. Antibiotic Prophylaxis in Trauma: Global Alliance for Infection in Surgery, Surgical Infection Society Europe, World Surgical Infection Society, American Association for the Surgery of Trauma, and World Society of Emergency Surgery Guidelines. — Coccolini F, Sartelli M, Sawyer R, et al. The Journal of Trauma and Acute Care Surgery. 2024.
11. Bite-Related and Septic Syndromes Caused by Cats and Dogs. — Oehler RL, Velez AP, Mizrachi M, Lamarche J, Gompf S. The Lancet. Infectious Diseases. 2009.
12. Primary Closure Versus Delayed or No Closure for Traumatic Wounds Due to Mammalian Bite. — Bhaumik S, Kirubakaran R, Chaudhuri S. The Cochrane Database of Systematic Reviews. 2019.
13. Prevention of Pertussis, Tetanus, and Diphtheria With Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). — Liang JL, Tiwari T, Moro P, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2018.